• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-34a 通过调节 Delta 样蛋白 1 抑制绒癌的发生。

MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.

机构信息

Department of Obstetrics and Gynaecology, The University of Hong Kong, Pokfulam Road, Hong Kong, China.

出版信息

BMC Cancer. 2013 Jan 18;13:25. doi: 10.1186/1471-2407-13-25.

DOI:10.1186/1471-2407-13-25
PMID:23327670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3561246/
Abstract

BACKGROUND

Choriocarcinoma is a gestational trophoblastic tumor which causes high mortality if left untreated. MicroRNAs (miRNAs) are small non protein-coding RNAs which inhibit target gene expression. The role of miRNAs in choriocarcinoma, however, is not well understood. In this study, we examined the effect of miR-34a in choriocarcinoma.

METHODS

MiR-34a was either inhibited or ectopically expressed transiently in two choriocarcinoma cell lines (BeWo and JEG-3) respectively. Its actions on cell invasion, proliferation and colony formation at low cell density were examined. The miR-34a putative target Notch ligand Delta-like 1 (DLL1) was identified by adoption of different approaches including: in-silico analysis, functional luciferase assay and western blotting. Real-time quantitative polymerase chain reaction was used to quantify changes in the expression of matrix proteinase in the treated cells. To nullify the effect of miR-34a ectopic expression, we activated Notch signaling through force-expression of the Notch intracellular domain in the miR-34a force-expressed cells. In addition, we studied the importance of DLL1 in BeWo cell invasion through ligand stimulation and antibody inhibition. Furthermore, the induction in tumor formation of miR-34a-inhibited BeWo cells in SCID mice was investigated.

RESULTS

Transient miR-34a force-expression significantly suppressed cell proliferation and invasion in BeWo and JEG-3 cells. In silicon miRNA target prediction, luciferase functional assays and Western blotting analysis demonstrated that miR-34a regulated DLL1 expression in both cell lines. Although force-expression of miR-34a suppressed the expression of DLL1 and NOTCH1, the extent of suppression was higher in DLL1 than NOTCH1 in both cell lines. MiR-34a-mediated DLL1 suppression led to reduced matrix metallopeptidase 9 and urokinase-type plasminogen activator expression. The effect of miR-34a on cell invasion was partially nullified by Notch signaling activation. DLL1 ligand stimulated while anti-DLL1 antibody treatment suppressed cell invasion. Mice inoculated with BeWo cells transfected with miR-34a inhibitor had significantly larger xenografts and stronger DLL1 expression than those with cells transfected with the control inhibitor.

CONCLUSIONS

MiR-34a reduced cell proliferation and invasiveness, at least, partially through its inhibitory effect on DLL1.

摘要

背景

绒癌是一种妊娠滋养细胞肿瘤,如果不治疗会导致高死亡率。微小 RNA(miRNA)是一种小的非蛋白编码 RNA,可抑制靶基因的表达。然而,miRNA 在绒癌中的作用尚不清楚。在这项研究中,我们研究了 miR-34a 在绒癌中的作用。

方法

分别在绒癌细胞系(BeWo 和 JEG-3)中转染 miR-34a 抑制剂或过表达 miR-34a,检测其对低细胞密度下细胞侵袭、增殖和集落形成的影响。采用不同方法(包括计算机分析、功能荧光素酶检测和 Western blot)鉴定 miR-34a 的潜在靶基因 Notch 配体 Delta-like 1(DLL1)。采用实时定量聚合酶链反应检测处理细胞中基质蛋白酶表达的变化。为了消除 miR-34a 过表达的影响,我们通过转染 Notch 胞内结构域激活 Notch 信号通路,从而过表达 Notch 信号通路。此外,我们通过配体刺激和抗体抑制研究了 DLL1 在 BeWo 细胞侵袭中的重要性。此外,我们还研究了 miR-34a 抑制的 BeWo 细胞在 SCID 小鼠中的肿瘤形成诱导作用。

结果

瞬时 miR-34a 过表达显著抑制了 BeWo 和 JEG-3 细胞的增殖和侵袭。在硅基 miRNA 靶位预测、荧光素酶功能检测和 Western blot 分析中,miR-34a 在两种细胞系中均调控 DLL1 的表达。尽管过表达 miR-34a 抑制了 DLL1 和 NOTCH1 的表达,但在两种细胞系中,DLL1 的抑制程度均高于 NOTCH1。miR-34a 介导的 DLL1 抑制导致基质金属蛋白酶 9 和尿激酶型纤溶酶原激活物表达减少。 Notch 信号通路的激活部分消除了 miR-34a 对细胞侵袭的影响。DLL1 配体刺激,而抗 DLL1 抗体处理抑制细胞侵袭。与转染对照抑制剂的细胞相比,转染 miR-34a 抑制剂的 BeWo 细胞接种的小鼠的异种移植物明显增大,DLL1 表达增强。

结论

miR-34a 通过抑制 DLL1 至少部分降低细胞增殖和侵袭能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/26775b443a45/1471-2407-13-25-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/903be4bce7ca/1471-2407-13-25-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/f5269d02c91a/1471-2407-13-25-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/bcc4019d6ac8/1471-2407-13-25-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/f6c2b87f01a8/1471-2407-13-25-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/26775b443a45/1471-2407-13-25-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/903be4bce7ca/1471-2407-13-25-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/f5269d02c91a/1471-2407-13-25-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/bcc4019d6ac8/1471-2407-13-25-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/f6c2b87f01a8/1471-2407-13-25-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f98/3561246/26775b443a45/1471-2407-13-25-5.jpg

相似文献

1
MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.微小 RNA-34a 通过调节 Delta 样蛋白 1 抑制绒癌的发生。
BMC Cancer. 2013 Jan 18;13:25. doi: 10.1186/1471-2407-13-25.
2
MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.微小 RNA-34a 通过下调宫颈癌和绒癌细胞中的 Notch1 和 Jagged1 抑制侵袭。
Carcinogenesis. 2010 Jun;31(6):1037-44. doi: 10.1093/carcin/bgq066. Epub 2010 Mar 29.
3
MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.miR-34a 靶向 Notch 配体 Delta-like 1 可抑制髓母细胞瘤中 CD15+/CD133+肿瘤起始细胞并支持其向神经分化。
PLoS One. 2011;6(9):e24584. doi: 10.1371/journal.pone.0024584. Epub 2011 Sep 12.
4
miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.miR-21在葡萄胎组织中过表达并促进绒毛膜癌细胞的增殖、迁移和侵袭。
Int J Gynecol Cancer. 2017 Feb;27(2):364-374. doi: 10.1097/IGC.0000000000000861.
5
Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.过表达 microRNA-34a 通过抑制 DLL1 克服结肠癌侧群细胞中 ABCG2 介导的 5-FU 耐药性。
J Biochem. 2020 Jun 1;167(6):557-564. doi: 10.1093/jb/mvaa012.
6
Verification of microRNA expression in human endometrial adenocarcinoma.人子宫内膜腺癌中微小RNA表达的验证
BMC Cancer. 2016 Apr 2;16:261. doi: 10.1186/s12885-016-2296-z.
7
MiR-34a Enhances Chondrocyte Apoptosis, Senescence and Facilitates Development of Osteoarthritis by Targeting DLL1 and Regulating PI3K/AKT Pathway.微小RNA-34a通过靶向DLL1并调节PI3K/AKT信号通路增强软骨细胞凋亡、衰老并促进骨关节炎的发展。
Cell Physiol Biochem. 2018;48(3):1304-1316. doi: 10.1159/000492090. Epub 2018 Jul 26.
8
Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.缺氧诱导的 microRNA-34a 下调通过靶向管状上皮细胞中的 Notch 信号通路促进 EMT。
PLoS One. 2012;7(2):e30771. doi: 10.1371/journal.pone.0030771. Epub 2012 Feb 17.
9
LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo.LINC00460 通过靶向 miR-149-5p/DLL1 轴并激活 Notch 通路,在体内外促进神经母细胞瘤肿瘤发生和顺铂耐药。
Drug Deliv Transl Res. 2024 Jul;14(7):2003-2018. doi: 10.1007/s13346-023-01505-6. Epub 2023 Dec 31.
10
Overexpression of hypoxia-inducible factor 1α induces migration and invasion through Notch signaling.缺氧诱导因子1α的过表达通过Notch信号通路诱导迁移和侵袭。
Int J Oncol. 2015 Aug;47(2):728-38. doi: 10.3892/ijo.2015.3056. Epub 2015 Jun 18.

引用本文的文献

1
Maternal plasma microRNAs as potential biomarkers for triaging pregnancies of unknown location and ectopic pregnancy diagnosis.母体血浆微小RNA作为对未知部位妊娠进行分类和诊断异位妊娠的潜在生物标志物。
Noncoding RNA Res. 2025 May 8;13:162-173. doi: 10.1016/j.ncrna.2025.05.005. eCollection 2025 Aug.
2
Mapping effective microRNA pairing beyond the seed using abasic modifications.利用无碱基修饰绘制种子区以外有效的微小RNA配对图谱。
Nucleic Acids Res. 2025 Apr 22;53(8). doi: 10.1093/nar/gkaf364.
3
Fungal protein D1 inhibits the proliferation of A549 cells via activating the p53/miR-34a signaling pathway.

本文引用的文献

1
The genetics of gestational trophoblastic disease: a rare complication of pregnancy.妊娠滋养细胞疾病的遗传学:一种罕见的妊娠并发症。
Cancer Genet. 2012 Mar;205(3):63-77. doi: 10.1016/j.cancergen.2012.01.004.
2
Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma.JAG1 的上调增强了肾上腺皮质癌中的细胞增殖。
Clin Cancer Res. 2012 May 1;18(9):2452-64. doi: 10.1158/1078-0432.CCR-11-2371. Epub 2012 Mar 16.
3
MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.
真菌蛋白D1通过激活p53/miR-34a信号通路抑制A549细胞的增殖。
J Nat Med. 2025 May;79(3):477-487. doi: 10.1007/s11418-024-01869-0. Epub 2025 Feb 18.
4
METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.METTL3通过HIF1AN诱导的HIF1A/VEGF通路失活,以m6A依赖的方式促进miR-21-5p成熟,从而加速绒毛膜癌进展。
Genes Genomics. 2022 Nov;44(11):1311-1322. doi: 10.1007/s13258-022-01309-x. Epub 2022 Sep 8.
5
miR-130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways.微小RNA-130b通过抑制DLL1和调节PI3K/Akt信号通路来抑制前列腺癌的侵袭和迁移。
Exp Ther Med. 2022 Jan;23(1):98. doi: 10.3892/etm.2021.11021. Epub 2021 Dec 1.
6
Bioinformatics Analysis of Choriocarcinoma-Related MicroRNA-Transcription Factor-Target Gene Regulatory Networks and Validation of Key miRNAs.绒毛膜癌相关微小RNA-转录因子-靶基因调控网络的生物信息学分析及关键微小RNA的验证
Onco Targets Ther. 2021 Jun 29;14:3903-3919. doi: 10.2147/OTT.S311291. eCollection 2021.
7
The comprehensive landscape of miR-34a in cancer research.miR-34a 在癌症研究中的全面概况。
Cancer Metastasis Rev. 2021 Sep;40(3):925-948. doi: 10.1007/s10555-021-09973-3. Epub 2021 May 6.
8
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.微小RNA能否成为改善罕见妇科癌症诊断和治疗的有用工具?简要概述。
Int J Mol Sci. 2021 Apr 7;22(8):3822. doi: 10.3390/ijms22083822.
9
Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel.评估 miR-34a 对 CCND1 mRNA 水平的影响及其对紫杉醇增敏作用的乳腺癌细胞系。
Iran Biomed J. 2020 Nov;24(6):361-9. doi: 10.29252/ibj.24.6.356. Epub 2020 Jun 2.
10
The Role of DLLs in Cancer: A Novel Therapeutic Target.DLLs在癌症中的作用:一种新型治疗靶点。
Onco Targets Ther. 2020 May 7;13:3881-3901. doi: 10.2147/OTT.S244860. eCollection 2020.
微小 RNA-34a 调节 c-Myc 转录复合物抑制人前列腺癌细胞的恶性转化。
PLoS One. 2012;7(1):e29722. doi: 10.1371/journal.pone.0029722. Epub 2012 Jan 3.
4
Sperm-borne microRNA-34c is required for the first cleavage division in mouse.精子携带的 microRNA-34c 对于小鼠的第一次卵裂是必需的。
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):490-4. doi: 10.1073/pnas.1110368109. Epub 2011 Dec 27.
5
MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.miRNA-34a 通过靶向 Fra-1 抑制结肠癌细胞的迁移和侵袭。
Carcinogenesis. 2012 Mar;33(3):519-28. doi: 10.1093/carcin/bgr304. Epub 2011 Dec 22.
6
p53 and microRNA-34 are suppressors of canonical Wnt signaling.p53 和 microRNA-34 是经典 Wnt 信号通路的抑制因子。
Sci Signal. 2011 Nov 1;4(197):ra71. doi: 10.1126/scisignal.2001744.
7
Wnt activation downregulates olfactomedin-1 in Fallopian tubal epithelial cells: a microenvironment predisposed to tubal ectopic pregnancy.Wnt 激活下调输卵管上皮细胞嗅鞘蛋白 1:易患输卵管异位妊娠的微环境。
Lab Invest. 2012 Feb;92(2):256-64. doi: 10.1038/labinvest.2011.148. Epub 2011 Oct 3.
8
MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.miR-34a 靶向 Notch 配体 Delta-like 1 可抑制髓母细胞瘤中 CD15+/CD133+肿瘤起始细胞并支持其向神经分化。
PLoS One. 2011;6(9):e24584. doi: 10.1371/journal.pone.0024584. Epub 2011 Sep 12.
9
miR-34a regulates mouse neural stem cell differentiation.miR-34a 调控小鼠神经干细胞分化。
PLoS One. 2011;6(8):e21396. doi: 10.1371/journal.pone.0021396. Epub 2011 Aug 3.
10
Reduction in miR-141 is induced by leukemia inhibitory factor and inhibits proliferation in choriocarcinoma cell line JEG-3.白血病抑制因子诱导 miR-141 减少,抑制绒癌细胞系 JEG-3 的增殖。
Am J Reprod Immunol. 2011 Jul;66 Suppl 1:57-62. doi: 10.1111/j.1600-0897.2011.01037.x.